Generlac Related Published Studies
Well-designed clinical trials related to Generlac (Lactulose)
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. [2011.08]
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. [2011.06]
Can partially hydrolyzed guar gum be an alternative to lactulose in treatment of childhood constipation? [2010.12]
Gastric emptying and orocaecal transit time of meals containing lactulose or inulin in men. [2010.08]
The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study. [2010.02]
Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. [2010.02]
The effects of lactulose supplementation to enteral feedings in premature
infants: a pilot study. [2010]
Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. [2009.09]
Carbohydrate intolerance in patients with self-reported food hypersensitivity: comparison of lactulose and glucose. [2009]
A dietary fiber mixture versus lactulose in the treatment of childhood constipation: a double-blind randomized controlled trial. [2008.11]
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. [2008.06]
Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit. [2008.05]
Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial. [2007.12]
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. [2007.09.04]
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. [2007.03]
Effect of lactulose on calcium and magnesium absorption: a study using stable isotopes in adult men. [2007.02]
Influence of long-term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects. [2006.12]
Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. [2006.10]
L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. [2006.08]
Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. [2006.07]
Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation. [2006.07]
Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial. [2006.04.15]
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. [2006.04.01]
Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. [2005.11]
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. [2005.10]
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. [2005.06.30]
Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B. [2005.05.21]
Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. [2005.03]
A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. [2005.02]
Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study. [2005]
L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate. [2004.11]
PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. [2004.11]
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. [2004.04.15]
Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. [2004.03]
[Effects of lactulose treatment on the course of subclinical hepatic encephalopathy] [2003.07.10]
[Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy] [2003.04]
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. [2003.02]
Effects of melatonin and lactulose on the liver and kidneys in rats with obstructive jaundice. [2002.12]
Short duration exercise increases breath hydrogen excretion after lactulose ingestion: description of a new phenomenon. [2002.11]
Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. [2002.05]
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. [2002]
Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. [2000.08]
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. [2000.03]
Effects of pre- and post-absorptive factors on the lactulose/rhamnose gut permeability test. [2000.03]
Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. [1999.08]
Well-designed clinical trials possibly related to Generlac (Lactulose)
Glutamine and Whey Protein Improve Intestinal Permeability and Morphology in Patients with Crohn's Disease: A Randomized Controlled Trial. [2011.10.26]
Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. [2011.10]
Evaluation of Early Enteral Feeding Through Nasogastric and Nasojejunal Tube in Severe Acute Pancreatitis: A Noninferiority Randomized Controlled Trial. [2011.07.14]
Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence. [2011.05]
Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. [2011.05]
Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain. [2011.04]
Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. [2011.01]
The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants. [2011.01]
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients
with hepatic encephalopathy. [2011]
Randomised clinical trial: the effects of perioperative probiotic treatment on
barrier function and post-operative infectious complications in colorectal cancer
surgery - a double-blind study. [2011]
[Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study]. [2010.12]
Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients. [2010.12]
Intestinal mucosal permeability of severely underweight and nonmalnourished Bangladeshi children and effects of nutritional rehabilitation. [2010.11]
Clinical trial: oral zinc in hepatic encephalopathy. [2010.11]
Gastric emptying of hexose sugars: role of osmolality, molecular structure and the CCK receptor. [2010.11]
[Effect of electroacupuncture of Tianshu (ST 25) on the rational symptoms of functional constipation patients and evaluation on its efficacy satisfaction: a single-center, prospective, practical and randomized control trial]. [2010.10]
Prophylactic use of laxative for constipation in critically ill patients. [2010.10]
Actions of prolonged ghrelin infusion on gastrointestinal transit and glucose homeostasis in humans. [2010.06]
Rifaximin treatment in hepatic encephalopathy. [2010.03.25]
Effects of vitamin A supplementation on intestinal barrier function, growth, total parasitic, and specific Giardia spp infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled trial. [2010.03]
Rifaximin treatment in hepatic encephalopathy. [2010]
Profound haemodilution during normothermic cardiopulmonary bypass influences neither gastrointestinal permeability nor cytokine release in coronary artery bypass graft surgery. [2009.10]
[The change of intestinal mucosa barrier in chronic severe hepatitis B patients and clinical intervention]. [2009.10]
A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. [2009.09]
Retroperitoneal repair of abdominal aortic aneurysm reduces bowel dysfunction. [2009.06]
Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in rural Bangladesh: a randomised double-blind controlled study. [2009.05]
Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571). [2009.03.18]
Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. [2009.02]
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. [2008.10.15]
[Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial] [2008.09.09]
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome. [2008.07.30]
Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. [2008.05]
Fluid restriction during running increases GI permeability. [2008.03]
Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates. [2008.02]
Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. [2008.02]
Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome. [2008.01]
Pain after inguinal hernia repair. Possible role of bowel preparation. [2007.11]
[Forlax in the treatment of childhood constipation: a randomized, controlled, multicenter clinical study.] [2007.10]
The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. [2007.09.01]
A comparison study between early enteral nutrition and parenteral nutrition in severe burn patients. [2007.09]
The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. [2007.09]
Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. [2007.08]
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. [2007.06.19]
[Electroacupuncture for treatment of acute pancreatitis and its effect on the intestinal permeability of the patient] [2007.06]
Effects of preoperatively selected gut decontamination on cardiopulmonary bypassjinduced endotoxemia. [2007.06]
Randomised clinical trial of a laxative alone versus a laxative and a bulking agent after primary repair of obstetric anal sphincter injury. [2007.06]
Enteral resuscitation and early enteral feeding in children with major burns--effect on McFarlane response to stress. [2007.06]
Peppermint oil (Mintoil((R))) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial. [2007.06]
A prospective randomized single-blind comparison of three methods of bowel preparation for outpatient flexible sigmoidoscopy. [2007.06]
Noninvasive measurement of transit time in short bowel syndrome. [2007.05]
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery. [2007.04.21]
The degree of breath methane production in IBS correlates with the severity of constipation. [2007.04]
Evaluation of early postoperative morbidity in pediatric tonsillectomy with the use of sucralfate. [2007.04]
Wasting and intestinal barrier function in children taking alanyl-glutamine-supplemented enteral formula. [2007.03]
Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. [2007.03]
Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. [2007.03]
|
